Boardroom Alpha
Boardroom Alpha
UAMY · Current Report (Form 8-K) · Filed June 16, 2026

United States Antimony Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 16, 2026
Period
Jun 12, 2026
Ticker
UAMY
Accession
0001104659-26-074161
Boardroom Alpha · Filing insights

All proposals approved at USAC's 2026 annual meeting: election of seven directors, charter amendment, and auditor ratification.

About United States Antimony Corp
Market cap
$726M
1Y TSR
+37.8%
3Y TSR
+135.1%
Board grade
C+
Sector
Basic Materials
CEO
Gary C Evan
Last annual meeting: Jun 12, 2026 · View full United States Antimony Corp profile →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported) June 12, 2026

 

  UNITED STATES ANTIMONY CORPORATION  
  (Exact name of registrant as specified in its charter)  

 

Texas   001-08675   81-0305822

(State or other jurisdiction

of incorporation) 

 

(Commission

File No.)

 

(IRS Employer

Identification Number)

 

4438 W. Lovers Lane, Unit 100, Dallas, TX   75209
(Address of principal executive officers)   (Zip Code)

 

Registrant’s telephone number, including area code: (406) 606-4117

  

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.01 par value   UAMY   NYSE American
Common Stock, $0.01 par value   UAMY   NYSE Texas

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

At the 2026 Annual Shareholders Meeting of United States Antimony Corporation (the “Company” and “USAC”) held on June 12, 2026 (“Annual Meeting”), each of the proposals submitted to a vote of the shareholders received the requisite votes for approval. Set forth below are the final voting results from the Company’s Annual Meeting for each of the proposals submitted to a vote of the shareholders:

 

1.To elect each of the seven directors named in the Proxy Statement for a term of one year

 

   FOR   AGAINST   ABSTAIN   BROKER NON-VOTES 
Gary C. Evans  43,201,379   -   5,914,028   40,638,002 
Dr. Blaise Aguirre  26,190,118   -   22,925,289   40,638,002 
Lloyd Joseph Bardswich  48,579,499   -   535,908   40,638,002 
Joseph A. Carrabba  38,505,154   -   10,610,253   40,638,002 
John M. Keane  47,603,382   -   1,512,025   40,638,002 
Jon R. Marinelli  43,014,787   -   6,100,620   40,638,002 
Michael A. McManus  38,515,214   -   10,600,193   40,638,002 

 

2.To approve an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the Company

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTES
73,504,344   15,313,484   935,581   -

 

3.To ratify the appointment of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTES
68,138,061   462,650   21,152,698   -

 

For more information about the foregoing proposals, see the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 20, 2026, the supplement filed with the Securities and Exchange Commission on April 27, 2026, and definitive additional materials on Schedule 14A filed with the Securities and Exchange Commission on June 8, 2026.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  UNITED STATES ANTIMONY CORPORATION
   
Dated: June 15, 2026 By: /s/ Shawn P. Winkler
  Shawn P. Winkler
  Interim Chief Financial Officer

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from United States Antimony Corp (UAMY)

Reference

Frequently asked questions

When did United States Antimony Corp file this 8-K?
United States Antimony Corp (UAMY) filed this Current Report (Form 8-K) with the SEC on June 16, 2026. The accession number assigned by EDGAR is 0001104659-26-074161.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All proposals approved at USAC's 2026 annual meeting: election of seven directors, charter amendment, and auditor ratification. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find United States Antimony Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K United States Antimony Corp has filed under CIK 101538, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer